SCA
CLVS

Secor Capital Advisors’s Clovis Oncology, Inc. CLVS Stock Holding History

Secor Capital Advisors’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-14,081
Closed -$193K – 698
2016
Q2 		$193K Sell
14,081
-292
-2% -$4.27K 0.02% 540
2016
Q1 		$276K Buy
+14,373
New +$304K 0.04% 455

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Secor Capital Advisors's CLVS Position: Q3 2016 in Review

Secor Capital Advisors sold out of Clovis Oncology, Inc. (CLVS) in Q3 2016, closing a stake of 14,081 shares — an estimated $193K sold.

Secor Capital Advisors first reported a position in CLVS in Q1 2016 and held it in 2 quarters. The position peaked at $276K in Q1 2016. 163 funds tracked by Wall St. Rank hold CLVS as of Q3 2016.

  • Secor Capital Advisors reported no remaining Clovis Oncology, Inc. position as of Q3 2016 after selling out during the quarter.
  • Secor Capital Advisors sold 14,081 Clovis Oncology, Inc. shares in Q3 2016, an estimated $193K.
  • Secor Capital Advisors first reported a position in Clovis Oncology, Inc. in Q1 2016 and held it in 2 quarters.
  • Secor Capital Advisors's Clovis Oncology, Inc. position peaked at $276K in Q1 2016.
  • 163 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2016.

Based on Secor Capital Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.